Former Laidlaw & Company (Uk) Ltd. Broker Robert Yasnis Investment Loss Options
Posted on Tuesday, April 27th, 2021 at 1:05 am
Were you the victim of former Laidlaw & Company (Uk) Ltd. broker Robert Yasnis (CRD# 2399141)? Yasnis has been registered with Worden Capital Management LLC in New York, New York since 2017. Previously, Yasnis was registered with Laidlaw & Company (Uk) Ltd. in Melville, New York from 2014 to 2017.
In June 2013, Florida opened an investigation into Yasnis with the following allegations: “making a material false statement on the application for registration.”
Yasnis has been the subject of four customer complaints between 2011 and 2020, two of which were denied, according to his CRD report. The most recent complaints are regarding:
December 2020. “Client alleges overconcentration, unsuitability and excessive trading.” The customer is seeking $148,119.20 in damages and the case is currently pending. The complaint was regarding equity OTC and common and preferred stocks. The complaint took place while Yasnis was registered with Laidlaw & Company (Uk) Ltd.
October 2016. “Customer alleges churning, excessive trading and unsuitability from 2014 to 2016.” The customer sought $76,300 in damages and the case was settled for $20,000. The complaint was regarding equity OTC and common and preferred stocks. The complaint took place while Yasnis was registered with Laidlaw & Company (Uk) Ltd.
Pursuant to FINRA Rules, member firms are responsible for supervising a broker’s activities during the time the broker is registered with the firm. Therefore, Laidlaw & Company (Uk) Ltd. may be liable for investment or other losses suffered by Yasnis’ customers.
Erez Law represents investors in the United States for claims against brokers and brokerage firms for wrongdoing. If you have experienced investment losses, please call us at 888-840-1571 or complete our contact form for a free consultation. Erez Law is a nationally recognized law firm representing individuals, trusts, corporations and institutions in claims against brokerage firms, banks and insurance companies on a contingency fee basis.